The method of manufacturing stem cells in a size appropriate for intravascular injections
This patent concerns the method of manufacturing stem cells in a size, i.e. a diameter of 11 to 16㎛, which is appropriate for intravascular injections. It is also regarding the culture medium used in the manufacture of stem cells in a size appropriate for intravascular injections
Using this patented method, stem cells can be manufactured in a size that is appropriate for intravascular injections, allowing the stem cells administered into the bloodstream to reach the target tissue area and effectively enhance the effectiveness of activation. Accordingly, it can substantially promote the efficacy of cell therapy in which stem cells are used.
Leave a reply
Leave a reply